The Gut-Cancer Axis: How the Microbiome Influences Tumor Biology
Understanding the Gut-Cancer Axis
What Is the Gut Microbiome?
The gut microbiome includes millions of bacteria, fungi, viruses, and archaea that work together to support digestion, nutrient absorption, and immune regulation. Now there is a connection between gut microbes and cancer development, aka the gut–cancer axis. Microbial activity in the intestine can influence processes such as inflammation, cell signaling, and immune surveillance, all of which affect cancer growth and progression.
When the microbial community remains balanced, it helps maintain immune homeostasis and protects the body from harmful pathogens and abnormal cells. However, dysbiosis can lead to chronic inflammation and create conditions that increase the risk of cancer development. Recent studies suggest that dysbiosis may be associated with colorectal, liver, pancreatic, and gastric cancers.
Dysbiosis, Inflammation, and Cancer Risk
Microorganisms in the gut produce a wide variety of metabolites that affect human health. Among the most important are short-chain fatty acids (SCFAs) such as butyrate, acetate, and propionate, which are produced when gut microbes ferment dietary fiber from plant-based foods. SCFAs provide energy to colon cells, strengthen the intestinal barrier, and regulate immune responses. Butyrate has demonstrated anti-cancer properties in several experimental studies. It can stop cancer cell growth, promote cell death, and reduce inflammation within the colon. Increasing dietary fiber intake can therefore support microbial production of these protective compounds and may contribute to cancer prevention.
The Mycobiome: Why Fungi Matter
Understanding the Mycobiome and Fungal Balance in the Gut
The gut mycobiome commonly includes species such as Candida, Saccharomyces, and Malassezia. In healthy individuals, these fungi coincide with bacterial populations in a balanced microbial environment. However, factors such as antibiotics, diet, illness, and stress can disrupt this balance. Fungal overgrowth or reduced fungal diversity may contribute to intestinal inflammation and disease. Studies have found that certain fungal species are more common in patients with inflammatory bowel disease and colorectal cancer, which suggests that fungal imbalance could play a role in influencing inflammation leading to cancer.
How Fungi Influence Immune Response and Antitumor Activity
Fungi interact with the immune system through specialized receptors that recognize fungal cell components. When these receptors are activated, immune cells release signaling molecules that regulate inflammation and defense mechanisms. Balanced fungal communities can support appropriate immune responses, including those involved in the identification and elimination of tumor cells. However, fungal dysbiosis may disrupt immune signaling and weaken antitumor activity. Some studies indicate that certain fungal species can stimulate inflammatory pathways that promote tumor growth, while others may enhance immune-mediated tumor suppression.
Fungi, Gut Health, and the Effectiveness of Cancer Treatment
Impact on Immunotherapy (e.g., Checkpoint Inhibitors) Efficacy
Immunotherapies, such as immune checkpoint inhibitors, have advanced cancer treatment by boosting the body’s ability to attack tumors. Although not all patients respond the same to these therapies. Evidence suggests that microbial diversity in the gut plays a role in determining treatment success. Furthermore, while much research has focused on bacteria, emerging studies indicate that fungal communities may also influence immunotherapy outcomes. Certain fungal profiles appear to support immune activation, while dysbiosis may reduce treatment effectiveness.
The Link Between Gut Dysbiosis (Fungal Overgrowth) and Chemotherapy Side Effects
Cancer treatments, including chemotherapy, can disrupt the balance of the gut microbiome. Antibiotics, immune suppression from steroid use, and medication-induced stress on the digestive system may allow opportunistic fungi to grow excessively. Also, fungal overgrowth may contribute to gastrointestinal inflammation, infections, and other complications during chemotherapy. Addressing microbial imbalance during treatment could help reduce these side effects and improve patient tolerance to therapy.
Dietary and Lifestyle Strategies for a Cancer-Fighting Gut
Supporting Fungal Balance with Targeted Probiotics and Prebiotics
Diet is one of the most powerful factors influencing the gut microbiome. Consuming a fiber-rich diet from fruits, vegetables, legumes, and whole grains supports a healthy gut and promotes SCFA production. Focus on consuming fermented foods such as yogurt, kefir, kimchi, and sauerkraut, which will provide healthy gut bacteria. Furthermore, reduce ultra-processed foods and excess sugars, as these can increase inflammation and disrupt the microbiome.
Additionally, fungal-specific probiotics are still under investigation, but could eventually help regulate both bacterial and fungal communities in the gut. Talk with a registered dietitian or your healthcare provider for more information.
Research and Future Directions in Mycobiome Modulation
The study of the gut mycobiome is still developing, but its implications for cancer research are promising. Future therapies may include personalized microbiome modulation strategies, such as diet-based interventions, probiotic treatments, or microbiota transplantation designed to optimize microbial balance.
FAQs
Can improving gut health lower your risk of cancer?
A healthy gut microbiome may help support normal immune function and reduce chronic inflammation, both of which play roles in overall health. Research suggests that diets rich in fiber, fruits, vegetables, legumes, and whole grains promote beneficial gut bacteria and the production of short-chain fatty acids, which have been associated with protective effects in the colon. However, maintaining a healthy microbiome is just one part of an overall cancer prevention strategy and does not guarantee protection against cancer.
What is the gut mycobiome?
The gut mycobiome refers to the community of fungi that naturally live alongside bacteria and other microorganisms in the digestive tract. Although fungi make up a much smaller portion of the gut microbiome than bacteria, they interact with the immune system and may influence inflammation, digestive health, and responses to certain diseases. Research on the mycobiome is still emerging, but scientists are increasingly recognizing its importance in overall gut health.
Do probiotics help prevent cancer?
There is currently no evidence that probiotic supplements can prevent cancer. Some studies suggest that maintaining a healthy gut microbiome may support immune function and reduce inflammation, and certain probiotics may help manage gastrointestinal side effects during cancer treatment. However, probiotic use should never replace standard cancer prevention strategies or medical treatment, and individuals undergoing cancer therapy should consult their healthcare team before starting supplements.
What foods support a healthy gut microbiome?
A diverse, fiber-rich diet is one of the best ways to support a healthy microbiome. Fruits, vegetables, whole grains, legumes, nuts, seeds, and fermented foods such as yogurt, kefir, kimchi, and sauerkraut provide nutrients that nourish beneficial gut microbes. Limiting ultra-processed foods and excess added sugars may also help maintain a healthier microbial balance.
References
1He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., Chen, M. X., Chen, Z. H., Ji, G. Y., Zheng, Z. D., Mujagond, P., Chen, X. J., Rong, Z. H., Chen, P., Lyu, L. Y., Wang, X., Wu, C. B., Yu, N., Xu, Y. J., Yin, J., … Zhou, H. W. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature medicine, 24(10), 1532–1535. https://doi.org/10.1038/s41591-018-0164-x
2Aykut, B., Pushalkar, S., Chen, R., Li, Q., Abengozar, R., Kim, J. I., Shadaloey, S. A., Wu, D., Preiss, P., Verma, N., Guo, Y., Saxena, A., Vardhan, M., Diskin, B., Wang, W., Leinwand, J., Kurz, E., Kochen Rossi, J. A., Hundeyin, M., Zambrinis, C., … Miller, G. (2019). The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature, 574(7777), 264–267. https://doi.org/10.1038/s41586-019-1608-2
3Underhill, D. M., & Iliev, I. D. (2014). The mycobiota: interactions between commensal fungi and the host immune system. Nature reviews. Immunology, 14(6), 405–416. https://doi.org/10.1038/nri3684
4McCulloch, J. A., Davar, D., Rodrigues, R. R., Badger, J. H., Fang, J. R., Cole, A. M., Balaji, A. K., Vetizou, M., Prescott, S. M., Fernandes, M. R., Costa, R. G. F., Yuan, W., Salcedo, R., Bahadiroglu, E., Roy, S., DeBlasio, R. N., Morrison, R. M., Chauvin, J. M., Ding, Q., Zidi, B., … Dzutsev, A. K. (2022). Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nature medicine, 28(3), 545–556. https://doi.org/10.1038/s41591-022-01698-2
5He, J., Chen, Y., Zhao, H., & Li, Y. (2025). The interplay between gut bacteria and targeted therapies: implications for future cancer treatments. Molecular medicine (Cambridge, Mass.), 31(1), 58. https://doi.org/10.1186/s10020-025-01108-6
6Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021). The microbiome and human cancer. Science (New York, N.Y.), 371(6536), eabc4552. https://doi.org/10.1126/science.abc4552
Recipes
Products
Comments
Join The Conversation...